MedTrace Logo

Comparison Between Raloxifene and Bazedoxifene

NCT01973738 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2016-10-19

No results posted yet for this study

Summary

Although there are two kinds of selective estrogen receptor modulator (SERM) :raloxifene (RLX) and bazedoxifene (BZA), the difference is still unclear. In this study, we plan to compare clinical efficacy and safety between RLX and BZA.

Conditions

  • Selective Estrogen Receptor Modulator

Sponsors & Collaborators

  • Toshihiko Kono

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01973738 on ClinicalTrials.gov